Monitor for actual sales filings (Form 4) in the coming weeks to confirm if and when the shares are sold. Officer-level sales are routine but should be watched for unusual volume or timing relative to company catalysts.
Price Chart
Executive Summary
Joanne Donovan, an officer of Edgewise Therapeutics, filed a Form 144 to notify intent to sell up to 71,588 shares of common stock. The shares were acquired through stock option exercises, an employee stock purchase plan, and restricted stock unit vesting.
Key Facts
- Joanne Donovan, an officer of Edgewise Therapeutics, intends to sell up to 71,588 shares.
- The shares consist of 50,000 from stock option exercises, 9,623 from an employee stock purchase plan, and 11,965 from restricted stock unit vesting.
- The filing was submitted on March 27, 2026, with the sales expected to occur over the next three months.
- No immediate sale has been reported; this is a notice of proposed sale.
Financial Impact
Approximately $2.27 million based on 71,588 shares at $31.70 per share (implied from filing data)
Risk Factors
- Perception of insider selling could weigh on investor sentiment, especially if sales occur near key company events.
- If the sales proceed, it may indicate reduced insider confidence, though the shares are from routine compensation vesting.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003048 |
| Document: 0001950047-26-003048-index.html | 0001950047-26-003048 |
| Document: 0001950047-26-003048.txt | 0001950047-26-003048 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Insider Cluster | $44.17 $44.62 | ▲ +1.02% | ▲ +3.01% | $41.22 (−6.68%) |
Aug 14, 2026 7w ago | Insider Cluster | $44.17 $44.62 | ▲ +1.02% | ▲ +3.01% | $41.22 (−6.68%) |
Aug 6, 2026 8w ago | 8-K | $44.42 $41.95 | ▼ −5.56% | ▼ −6.16% | $41.22 (−7.20%) |
Jul 13, 2026 11w ago | 8-K | $41.27 $44.58 | ▲ +8.02% | ▲ +4.84% | $41.22 (−0.12%) |
Jun 1, 2026 17w ago | 8-K | $40.26 $40.63 | ▲ +0.92% | ▲ +2.22% | $41.22 (+2.38%) |
May 7, 2026 21w ago | 8-K | $35.58 $36.21 | ▲ +1.77% | ▼ −1.37% | $41.22 (+15.85%) |
Apr 23, 2026 23w ago | DEFA14A | $31.58 $32.69 | ▲ +3.51% | ▼ −0.51% | $41.22 (+30.53%) |
Mar 27, 2026 26w ago | 144 | $30.28 $30.99 | ▲ +2.34% | ▼ −10.25% | $41.22 (+36.13%) |
Feb 26, 2026 31w ago | 8-K | $29.66 $31.65 | ▲ +6.71% | ▲ +13.11% | $41.22 (+38.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access